QUVIVIQ
Live / Registered — Registered (as of 02 Apr 2024)
What this means for you
Registered since 02 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79350361
- Registration number
- 7341596
- Mark type
- Stylized text
- Filed
- 06 Jul 2022
- Published for opposition
- 16 Jan 2024
- Registered
- 02 Apr 2024
- Attorney of record
- Mary Margaret L. O'Donnell
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations intended for the prevention or treatment of cardiovascular diseases, hypertension, cerebral haemorrhages and sequela thereof, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergy diseases, autoimmune diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, central nervous system diseases and disorders, dementia, insomnia, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage diseases, Fabry disease and Fabry disease symptoms and sequela, infectious diseases and cancer
Owner
Prosecution history
- 02 Nov 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 17 Oct 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 17 Oct 2024 — FINAL DISPOSITION PROCESSED
- 03 Jul 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 02 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jan 2024 — PUBLISHED FOR OPPOSITION
- 13 Jan 2024 — NOTIFICATION PROCESSED BY IB
- 27 Dec 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 27 Dec 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 27 Dec 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Dec 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Dec 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Dec 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE